We are proud to announce that Dr. Liliya Mihaylova was promoted to Associate Professor in Pharmacology!

 

On September 17 at the Stephan Angeloff Institute of Microbiology at the Bulgarian Academy of Sciences, a 7-member scientific jury unanimously approved the habilitation work of Dr. Mihaylova and promoted her to Associate Professor. The major part of her habilitation work was related to the PlanaSYST project in which Liliya worked as a PostDoc under the supervision of Prof. Dr. Milen I. Georgiev. Over the past 7 years she has published more than 30 scientific papers dedicated to the investigation of the biological activity of natural compounds against obesity and age-related metabolic disorders through combining approaches of molecular pharmacology, metabolomics and plant biotechnology.

Assoc. Prof. Dr. Liliya V. Mihaylova will further dedicate her scientific efforts at CPSBB to the in-depth study of the molecular mechanisms of obesity and specifically the role of mitochondria and heritable factors across generations that potentially increase the risk of metabolic disorders. The main goal is to discover natural substances with biological activity that could prevent and control metabolic disruptions and obesity development.

On November 18,  Assoc. Prof. Dr. Mihaylova has been awarded with her first scientific grant from the Bulgarian National Science Fund, which she will implement jointly at CPSBB and the Stephan Angeloff Institute of Microbiology for the next 3 years. The project entitled “Cross-talk between PI3K/AKT/GSK3 and AMPK/SIRT1 signaling pathways in the development of obesity and metabolic disorders – a molecular pharmacological approach to study triterpenoids” is aiming at investigating the critical signaling pathways in the development of obesity and the possibility of pharmacological modulation of these molecular signaling networks by natural triterpene compounds in a model system of obesity in Caenorhabditis elegans. Integrating in vivo models of obesity and stress with metabolomic analysis, will make a significant contribution to the field of molecular pharmacology.